Quality of Life, Perception of Disease and Coping Strategies in Patients with Hemophilia in Spain and El Salvador: A Comparative Study.
coping strategies
hemophilia
illness perception
joint disease
quality of life
Journal
Patient preference and adherence
ISSN: 1177-889X
Titre abrégé: Patient Prefer Adherence
Pays: New Zealand
ID NLM: 101475748
Informations de publication
Date de publication:
2021
2021
Historique:
received:
24
06
2021
accepted:
31
07
2021
entrez:
30
8
2021
pubmed:
31
8
2021
medline:
31
8
2021
Statut:
epublish
Résumé
Hemophilia is characterized by the development of joint bleeds that cause long-term joint damage (hemophilic arthropathy). Joint damage leads to disability and affects psychosocial aspects in patients with hemophilia. To compare the clinical situation, perception of disease and quality of life, and coping strategies in adult patients with hemophilia in El Salvador and Spain. In this comparative clinical study, 43 patients with hemophilia aged between 18 and 50 years old from Spain and El Salvador participated. After obtaining the patients' consent, they completed the Illness Perception Questionnaire-Revised (IPQ-R), Hemophilia-QoL and Inventory of Coping strategies questionnaires. Joint status was assessed using the Hemophilia Joint Health Score and based on a record of clinical and treatment data. Hemophilia patients from Spain showed an improved perception of quality of life (p <0.05), although there were only differences in the self-criticism variable (p = 0.04) for coping strategies. Joint damage and age correlated (p <0.05) negatively with perception of disease, perceived quality of life and coping strategies in both populations. There were differences (p <0.05) between the two populations based on HIV and HCV coinfections in perception of disease and perceived quality of life. Patients with hemophilia in El Salvador exhibit a poorer perception of disease and quality of life. Despite differences in access to treatment from one country to the other, there is no difference in coping with the disease. Older patients are better able to adapt to the disease.
Sections du résumé
BACKGROUND
BACKGROUND
Hemophilia is characterized by the development of joint bleeds that cause long-term joint damage (hemophilic arthropathy). Joint damage leads to disability and affects psychosocial aspects in patients with hemophilia.
OBJECTIVE
OBJECTIVE
To compare the clinical situation, perception of disease and quality of life, and coping strategies in adult patients with hemophilia in El Salvador and Spain.
METHODS
METHODS
In this comparative clinical study, 43 patients with hemophilia aged between 18 and 50 years old from Spain and El Salvador participated. After obtaining the patients' consent, they completed the Illness Perception Questionnaire-Revised (IPQ-R), Hemophilia-QoL and Inventory of Coping strategies questionnaires. Joint status was assessed using the Hemophilia Joint Health Score and based on a record of clinical and treatment data.
RESULTS
RESULTS
Hemophilia patients from Spain showed an improved perception of quality of life (p <0.05), although there were only differences in the self-criticism variable (p = 0.04) for coping strategies. Joint damage and age correlated (p <0.05) negatively with perception of disease, perceived quality of life and coping strategies in both populations. There were differences (p <0.05) between the two populations based on HIV and HCV coinfections in perception of disease and perceived quality of life.
CONCLUSION
CONCLUSIONS
Patients with hemophilia in El Salvador exhibit a poorer perception of disease and quality of life. Despite differences in access to treatment from one country to the other, there is no difference in coping with the disease. Older patients are better able to adapt to the disease.
Identifiants
pubmed: 34456562
doi: 10.2147/PPA.S326434
pii: 326434
pmc: PMC8387734
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1817-1825Informations de copyright
© 2021 Cuesta-Barriuso et al.
Déclaration de conflit d'intérêts
The authors state they have no interests that might be perceived as posing a conflict or bias for this work.
Références
Haemophilia. 2016 Jul;22(4):499-506
pubmed: 27075653
Blood. 2009 Dec 17;114(26):5256-63
pubmed: 19837978
Haemophilia. 2000 Sep;6(5):471-3
pubmed: 11012687
Eur J Pain. 2013 Jul;17(6):929-38
pubmed: 23242704
Haemophilia. 1995 Apr;1 Suppl 2:4-5
pubmed: 27214839
Haemophilia. 2002 May;8(3):205-10
pubmed: 12010412
Thromb Res. 2011 Jan;127 Suppl 1:S10-3
pubmed: 21056901
Pharmacol Res. 2017 Jan;115:192-199
pubmed: 27890816
Haemophilia. 2017 Jul;23(4):556-565
pubmed: 28419637
Haemophilia. 2001 Jan;7(1):53-63
pubmed: 11136382
Haemophilia. 2014 Jul;20(4):513-8
pubmed: 24456085
Psychosom Med. 1995 Jan-Feb;57(1):32-6
pubmed: 7732156
Haemophilia. 2005 Jul;11(4):360-5
pubmed: 16011588
Aten Primaria. 2012 May;44(5):280-7
pubmed: 21955598
Haemophilia. 2017 May;23(3):e180-e187
pubmed: 28393468
Br J Haematol. 2015 Jun;169(6):777-86
pubmed: 25819695
Haemophilia. 2020 Aug;26 Suppl 6:1-158
pubmed: 32744769
Eur J Haematol. 2014 Jun;93 Suppl 75:9-18
pubmed: 24966141
Eur J Haematol. 2015 Oct;95(4):336-41
pubmed: 25600259
Haemophilia. 2011 Jan;17(1):21-7
pubmed: 20579110
Transfusion. 1965 Nov-Dec;5(6):533-8
pubmed: 5323791
AIDS Behav. 2009 Apr;13(2):258-67
pubmed: 17705096
Haemophilia. 2005 Nov;11(6):603-10
pubmed: 16236110
Actas Esp Psiquiatr. 2007 Jan-Feb;35(1):29-39
pubmed: 17323223
Haemophilia. 2007 May;13(3):305-10
pubmed: 17498080
Haemophilia. 2012 May;18(3):e101-14
pubmed: 22059839
Arthritis Care Res (Hoboken). 2011 Feb;63(2):223-30
pubmed: 20862683
Haemophilia. 2008 Sep;14(5):1014-22
pubmed: 18624702
Haemophilia. 2003 Sep;9(5):619-24
pubmed: 14511304
Thromb Haemost. 2015 Jul;114(1):35-45
pubmed: 25855376
Haemophilia. 2005 Jan;11(1):43-8
pubmed: 15660988
Vox Sang. 2017 May;112(4):301-309
pubmed: 28299792
Haemophilia. 2015 Sep;21(5):598-604
pubmed: 25684356